| RS1768358162 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1768359621 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1768361715 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1768367412 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1768371329 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1768373125 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1768377655 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1768381543 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1768382090 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1768386253 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1768387288 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1768389030 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1768393965 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1768394971 |
CNPY3
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 60 |
| RS1768400035 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1768416586 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1768488927 |
COL12A1
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 2, Bethlem myopathy 2 |
| RS1768495540 |
COL12A1
|
Health Risk |
Likely pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1768517145 |
SIL1
|
Health Risk |
Pathogenic |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS1768581035 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS1768621810 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1768621880 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1768622603 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1768627952 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1768634470 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia 3 |
| RS1768655161 |
ADGRV1
|
Health Risk |
Likely pathogenic |
— |
| RS1768657480 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1768702301 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1768708203 |
COL12A1
|
Health Risk |
Likely pathogenic |
— |
| RS1768754157 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1768790302 |
GTPBP2
|
Health Risk |
Likely pathogenic |
Jaberi-Elahi syndrome, Jaberi-Elahi syndrome |
| RS1768796944 |
FNIP1
|
Health Risk |
Pathogenic |
— |
| RS1768797517 |
TULP1
|
Health Risk |
Pathogenic |
— |
| RS1768803733 |
TULP1
|
Health Risk |
Pathogenic |
— |
| RS1768809177 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1768838504 |
SGCD
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L |
| RS1768907217 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1768930040 |
CD2AP
|
Health Risk |
Likely pathogenic |
CD2AP-related disorder, CD2AP-related disorder |
| RS1768947396 |
SLC17A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialic acid storage disease, severe infantile type |
| RS1768947811 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS1768948534 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Sialic acid storage disease, severe infantile type |
| RS1768955731 |
RARS2
|
Health Risk |
Pathogenic |
— |
| RS1768957914 |
TAP2
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency 2 |
| RS1768958447 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1769021763 |
SLC17A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Sialic acid storage disease, severe infantile type |
| RS1769042136 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS1769045757 |
COL12A1
|
Health Risk |
Pathogenic |
Ullrich congenital muscular dystrophy 2, Ullrich congenital muscular dystrophy 2 |
| RS1769050790 |
CD2AP
|
Health Risk |
Pathogenic |
— |
| RS1769085821 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1B |
| RS1769124033 |
SLC17A5
|
Health Risk |
Likely pathogenic |
Salla disease, Salla disease |
| RS1769129693 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS1769133149 |
TAP2
|
Health Risk |
Pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS1769138467 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769147841 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769153825 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769197412 |
PHIP
|
Health Risk |
Pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1769225531 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia 3 |
| RS1769229991 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769232570 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769233531 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1769239782 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769260264 |
COL12A1
|
Health Risk |
Pathogenic |
— |
| RS1769267226 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 25 |
| RS1769272826 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1769303765 |
SLC17A5
|
Health Risk |
Pathogenic |
Salla disease, Salla disease |
| RS1769342165 |
TAP2
|
Health Risk |
Likely pathogenic |
MHC class I deficiency, MHC class I deficiency |
| RS1769469813 |
EYS
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa |
| RS1769471082 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1769471435 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1769476342 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1769479905 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1769508571 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769515132 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769605097 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769631840 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS1769657526 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1769668162 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1769669798 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1769684609 |
OCLN
|
Health Risk |
Likely pathogenic |
— |
| RS1769688206 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 4A (Zellweger), Peroxisome biogenesis disorder 4A (Zellweger) |
| RS1769690100 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1769692830 |
LCA5
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1769694196 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1769695958 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS1769696205 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1769703329 |
LCA5
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1769706250 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1769707298 |
LCA5
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1769707423 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS1769710277 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS1769712635 |
PEX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 4A (Zellweger), Peroxisome biogenesis disorder |
| RS1769760726 |
DNAH8
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1769761816 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1769762719 |
LCA5
|
Health Risk |
Pathogenic |
— |
| RS1769772582 |
PEX6
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS1769796270 |
NT5E
|
Health Risk |
Likely pathogenic |
NT5E-related disorder, NT5E-related disorder |
| RS1769818844 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder 4A (Zellweger) |
| RS1769843934 |
LCA5
|
Health Risk |
Likely pathogenic |
— |
| RS1769845495 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1769875600 |
PEX6
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |